Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exelixis, Inc. - Common Stock (NQ:EXEL)

43.37 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,218
Open 43.37
Bid (Size) 44.27 (1)
Ask (Size) 46.50 (1)
Prev. Close 43.37
Today's Range 43.37 - 43.37
52wk Range 21.82 - 49.62
Shares Outstanding 315,048,788
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug
CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug. 
Via Investor's Business Daily
Kroger Posts Better-Than-Expected Earnings, Joins Couchbase, CarMax And Other Big Stocks Moving Higher On Friday
Via Benzinga

Performance

YTD
+27.8%
+27.8%
1 Month
+0.6%
+0.6%
3 Month
+15.0%
+15.0%
6 Month
+29.5%
+29.5%
1 Year
+94.3%
+94.3%

More News

Read More
Exelixis' Zanzalintinib Combo Boosts Survival In Colorectal Cancer, Stock Soars
Via Benzinga
AMD To Rally More Than 36%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Analyst Expectations For Exelixis's Future
Via Benzinga
Exelixis Catapults 14% On Positive Results For Next-Gen Colon Cancer Drug
Via Investor's Business Daily
Exposures Product Safety
What 9 Analyst Ratings Have To Say About Exelixis
Via Benzinga
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Sequans Communications Shares Are Trading Higher By Over 42%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer
From Exelixis, Inc.
Via Business Wire
Exelixis’ Partner Ipsen Receives Positive CHMP Opinion for CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors
From Exelixis, Inc.
Via Business Wire
EXELIXIS INC (NASDAQ:EXEL) – A Strong Contender for Growth Investors
Via Chartmill
EXELIXIS INC (NASDAQ:EXEL) – A Strong Growth Stock with Attractive Valuation
Via Chartmill
DoorDash To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
EXELIXIS INC (NASDAQ:EXEL) – A Strong Contender in Undervalued Biotech Stocks
Via Chartmill
EXELIXIS INC (NASDAQ:EXEL) – A High-Growth Momentum Stock with Strong Technical Setup
Via Chartmill
EXELIXIS INC (NASDAQ:EXEL) – A Strong Growth Stock with Technical Breakout Potential
Via Chartmill
2 Top Stocks to Buy With Less Than $100
Via The Motley Fool
Exposures Product Safety
EXELIXIS INC (NASDAQ:EXEL) – A Strong Contender for Growth Investors
Via Chartmill
Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025
From Exelixis, Inc.
Via Business Wire
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May and June
From Exelixis, Inc.
Via Business Wire
EXELIXIS INC (NASDAQ:EXEL) – A Strong Growth Stock with Attractive Valuation
Via Chartmill
EXELIXIS INC (NASDAQ:EXEL) – An Undervalued Biotech Stock with Strong Fundamentals
Via Chartmill
CoreWeave, Super Micro Computer And Coinbase Are Among Top 11 Large-Cap Gainers Last Week (May 12-May 16): Are The Others In Your Portfolio?
Via Benzinga

Frequently Asked Questions

Is Exelixis, Inc. - Common Stock publicly traded?
Yes, Exelixis, Inc. - Common Stock is publicly traded.
What exchange does Exelixis, Inc. - Common Stock trade on?
Exelixis, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exelixis, Inc. - Common Stock?
The ticker symbol for Exelixis, Inc. - Common Stock is EXEL on the Nasdaq Stock Market
What is the current price of Exelixis, Inc. - Common Stock?
The current price of Exelixis, Inc. - Common Stock is 43.37
When was Exelixis, Inc. - Common Stock last traded?
The last trade of Exelixis, Inc. - Common Stock was at 06/23/25 04:00 PM ET
What is the market capitalization of Exelixis, Inc. - Common Stock?
The market capitalization of Exelixis, Inc. - Common Stock is 13.66B
How many shares of Exelixis, Inc. - Common Stock are outstanding?
Exelixis, Inc. - Common Stock has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.